Kallikrein 7 Protein (KLK7) (AA 28-253)
-
- Target Alle Kallikrein 7 (KLK7) Proteine anzeigen
- Kallikrein 7 (KLK7)
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 28-253
-
Spezies
- Human
-
Quelle
- Hefe
- Applikation
- SDS-PAGE (SDS)
- Sequenz
- HHSSGLVPRG SHMDDDDKII DGAPCARGSH PWQVALLSGN QLHCGGVLVN ERWVLTAAHC KMNEYTVHLG SDTLGDRRAQ RIKASKSFRH PGYSTQTHVN DLMLVKLNSQ ARLSSMVKKV RLPSRCEPPG TTCTVSGWGT TTSPDVTFPS DLMCVDVKLI SPQDCTKVYK DLLENSMLCA GIPDSKKNAC NGDSGGPLVC RGTLQGLVSW GTFPCGQPND PGVYTQVCKF TKWINDTMKK HR
- Aufreinigung
- SDS-PAGE
- Reinheit
- > 90 %
- Top Product
- Discover our top product KLK7 Protein
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.1-2 mg/mL
- Buffer
- 20 mM Tris-HCl based buffer, pH 8.0
- Lagerung
- -80 °C,4 °C,-20 °C
- Informationen zur Lagerung
- Store at -20°C, for extended storage, conserve at -20°C or -80°C. Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
-
- Target
- Kallikrein 7 (KLK7)
- Andere Bezeichnung
- KLK7 (KLK7 Produkte)
- Hintergrund
- May catalyze the degradation of intercellular cohesive structures in the cornified layer of the skin in the continuous shedding of cells from the skin surface. Specific for amino acid residues with aromatic side chains in the P1 position. Cleaves insulin A chain at '14-Tyr-|-Gln-15' and insulin B chain at '6-Leu-|-Cys-7', '16-Tyr-|-Leu-17', '25-Phe-|-Tyr-26' and '26-Tyr-|-Thr-27'. Could play a role in the activation of precursors to inflammatory cytokines.
- Molekulargewicht
- 26.4 kDa
- UniProt
- P49862
- Pathways
- Komplementsystem
-